In today’s recent session, 0.96 million shares of the Guardant Health Inc (NASDAQ:GH) have been traded, and its beta is 1.38. Most recently the company’s share price was $51.49, and it changed around $1.96 or 3.96% from the last close, which brings the market valuation of the company to $6.38B. GH at last check was trading at a discount to its 52-week high of $52.92, offering almost -2.78% off that amount. The share price’s 52-week low was $20.14, which indicates that the recent value has risen by an impressive 60.89% since then. We note from Guardant Health Inc’s average daily trading volume that its 10-day average is 2.22 million shares, with the 3-month average coming to 2.19 million.
Guardant Health Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.54. If we narrow it down even further, the data shows that 0 out of 25 analysts rate the stock as a Sell; another 7 rate it as Overweight. Among the rest, 3 recommended GH as a Hold, whereas 15 deemed it a Buy, and 0 rated it as Underweight.
Guardant Health Inc (NASDAQ:GH) trade information
Instantly GH has been showing a green trend so far today with a performance of 3.96% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 51.25 on recent trading daydecreased the stock’s daily price by -0.47%. The company’s shares are currently up 68.54% year-to-date, but still up 5.02% over the last five days. On the other hand, Guardant Health Inc (NASDAQ:GH) is 27.96% up in the 30-day period. We can see from the shorts that 8.87 million shares have been sold at a short interest cover period of 3.56 day(s).
The consensus price target as assigned by Wall Street analysts is $52, which translates to bulls needing to increase their stock price by 0.98% from its current value. Analyst projections state that GH is forecast to be at a low of $52 and a high of $52.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -33.61%. Guardant Health Inc earnings are expected to increase by 22.63% in 2025, but the outlook is positive 21.91% per year for the next five years.
GH Dividends
Guardant Health Inc’s next quarterly earnings report is expected to be released on 2025-Apr-30.
Guardant Health Inc (NASDAQ:GH)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 4.59% of Guardant Health Inc shares, and 97.73% of them are in the hands of institutional investors. The stock currently has a share float of 102.43%. Guardant Health Inc stock is held by 464.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 9.5035% of the shares, which is about 11.64 million shares worth $336.07 million.
BLACKROCK INC., with 9.1777% or 11.24 million shares worth $324.55 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
